|
MechanismTRPC5 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shenzhen Jingegg Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Shenzhen Jingegg Biomedical Technology Co., Ltd.
100 Deals associated with Shenzhen Jingegg Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Shenzhen Jingegg Biomedical Technology Co., Ltd.